Is Alimentation Couche-Tard (TSX:ATD.B) a Buy After a Strong Q4?

Alimentation Couche-Tard (TSX:ATD.B) beat on both the top and bottom lines in Q4. Is this top growth stock a buy today?

Over the past decade, Alimentation Couche-Tard (TSX:ATD.B) has been one of the most reliable stocks on the index. Over this period, the stock has returned 1,290%, and shareholders have been well rewarded

Although it initially suffered a setback due to the pandemic, Alimentation is rebounding in a big way. After losing as much as 25% of its value at the peak, on Tuesday the stock closed at $42.60, up by 3.37% year to date. 

As with most companies, expectations were low heading into earnings. How did Alimentation Couche-Tard perform? Let’s take a look. 

The earnings report

After the bell on Tuesday, the company reported fourth-quarter and year-end results, which ended April 26, 2020:

Metric Reported Expected
Earnings per share $0.47 $0.43
Revenue $9.69 billion $9.36 billion

All things considered, it was a decent quarter for Alimentation Couche-Tard. Earnings of $0.47 per share beat by $0.04, and revenue of $9.69 billion beat by $330 million. 

Year over year, revenue dropped by 26.1% and full-year revenue of $59.12 billion dropped by 8.4% over fiscal 2019. As a leading convenience store and fuel retail company, it is not surprising that the pandemic took a chunk out of sales.

The road transportation fuel segment saw the biggest impact, as fuel volumes decreased by 18.5% in the U.S., 13.4% in Europe, and 23.5% in Canada. On the bright side, lower volumes were partially offset by higher margins.

In the merchandise and services segment, lower volumes were offset by higher average purchases. This led to a respectable drop of 2.6% year over year (YOY). 

Likewise, Alimentation Couche-Tard has plenty of cash to hold it over. The company exited the quarter in a strong financial position with more than $4.7 billion in liquidity at its disposal. It also de-leveraged, with the company’s debt ratio improving to 1.60:1 as of end of fiscal 2020, down from 2.18:1 in the previous year. 

Despite the material impact of the pandemic, Alimentation Couche-Tard still grew adjusted EBITDA by 11.9% on the year — a big accomplishment considering the economy took a big downturn. 

The year ahead

What will the next quarter look like? Unfortunately, the company’s earnings release did little to provide clarity. On the bright side, the company did mention that volumes began stabilizing in April. 

Have volumes since risen? How are they when one compares to this time last year? Unfortunately, these are answers investors do not yet have.

Likewise, Alimentation Couche-Tard is incurring additional expenses, as it looks to prioritize the safety of its employees and customers. Some of these are one-time expenses, while others are likely to continue in the near future. These include additional cleaning and sanitizing supplies, masks, and gloves for employees and an emergency pay premium of $2.50 per hour. 

Given this, and considering the economy is not yet fully re-opened, investors can expect the next quarter to also see considerable YOY weakness.  

Is Alimentation Couche-Tard a buy today?

Alimentation Couche-Tard has made a name for itself by making transformative acquisitions. This led to outsized growth and market-beating returns. Although this is still a well-run company, investors should temper growth expectations. 

It is likely the company will focus on reducing costs and conserving cash so long as economic uncertainty remains. In the meantime, this is a quality company that is worthy of investors’ attention, and I maintain a positive outlook on the company. 

Fool contributor Mat Litalien has no position in any of the stocks mentioned. The Motley Fool recommends ALIMENTATION COUCHE-TARD INC.

More on Investing

Person holding a smartphone with a stock chart on screen
Dividend Stocks

Enbridge Is Great, But I Think This Stock Could Be a Better Buy

Enbridge may be the safer dividend giant, but BCE’s beaten-down shares could offer the bigger rebound if its turnaround works.

Read more »

Colored pins on calendar showing a month
Dividend Stocks

What Your TFSA Could Look Like With $10,000 and Earning $41 in Monthly Income

CT REIT (TSX:CRT.UN) looks like the ultimate passive income play for Canadians in July and beyond.

Read more »

View of high rise corporate buildings in the financial district of Toronto, Canada
Dividend Stocks

1 Canadian Dividend Stock Down 24% to Buy and Hold Forever

Allied Properties REIT is down sharply from its highs. Here is why this Canadian dividend stock could still be worth…

Read more »

Printing canadian dollar bills on a print machine
Dividend Stocks

How to Use Just $20,000 to Turn Your TFSA into a Reliable Cash-Generating Machine

Given their resilient business models, healthy cash flows, and attractive dividend yields, these two monthly dividend stocks are excellent choices…

Read more »

a person watches stock market trades
Dividend Stocks

Analysts Agree These Canadian Stocks Are Strong Buys

Three very different Canadian stocks are drawing rare agreement from Bay Street analysts, and each has a clear growth engine…

Read more »

A close up color image of a small green plant sprouting out of a pile of Canadian dollar coins "loonies."
Dividend Stocks

Why Canadian Dividend ETFs Could Be the Simplest Way to Defend Your Portfolio

Dividend investing isn't a perfect strategy, but it's "good enough" for beginner investors.

Read more »

Digital background depicting innovative technologies in quantum computing, (AI) artificial systems, neural interfaces and internet machine learning technologies
Tech Stocks

2 Canadian AI Stocks That Could Turn $5,000 Into $50,000

A $5,000 split between two Canadian tech names could ride AI in cars and corporate training toward long-term, 10-fold upside.

Read more »

Doctor talking to a patient in the corridor of a hospital.
Dividend Stocks

A TFSA Pick Yielding 6.2% With Dependable Cash Payments

Vital Infrastructure Properties is a top TFSA stock that's benefitting from strong industry trends in healthcare real estate.

Read more »